Home/Filings/4/0001437749-25-019958
4//SEC Filing

Disbrow Jarrett 4

Accession 0001437749-25-019958

CIK 0001385818other

Filed

Jun 9, 8:00 PM ET

Accepted

Jun 10, 3:06 PM ET

Size

5.0 KB

Accession

0001437749-25-019958

Insider Transaction Report

Form 4
Period: 2025-06-09
Disbrow Jarrett
Chief Business Officer
Transactions
  • Purchase

    Common Stock

    2025-06-09$1.50/sh+16,666$24,99929,462 total
Footnotes (2)
  • [F1]Purchased pursuant to the Issuer's registered offering more particularly described on the Registration Statement on Form S-1, as amended, filed by the Issuer on June 2, 2025.
  • [F2]Total reflects 1-to-20 reverse stock split effected by the Issuer on January 6, 2023.

Issuer

AYTU BIOPHARMA, INC

CIK 0001385818

Entity typeother

Related Parties

1
  • filerCIK 0001640724

Filing Metadata

Form type
4
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 3:06 PM ET
Size
5.0 KB